← All Sponsors

SPONSOR

Centre Hospitalier Universitaire Dijon

Total Trials

18

Recruiting

18

Phases

Phase 3

Conditions studied: Humeral Shaft Fracture CVA, Dijon Registry Common Non-specific Low Back Pain Facioscapulohumeral Dystrophy Cirrhosis Presbyacousie Multiple Endocrine Neoplasia Von Willebrand Diseases Major Constitutional Thrombopathy Patient on Antiplatelet Drugs

NCT05877014 Phase 3

Unipolar Versus Bipolar Interlocking in Humeral Shaft Fractures in Adults

Humeral Shaft Fracture

Dijon Stroke Cohort

CVA, Dijon Registry

Impact of Motor Imagery in the Functional Rehabilitation of Patients With Chronic Low Back Pain: a Randomised Controlled Trial

Common Non-specific Low Back Pain

Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies

Facioscapulohumeral Dystrophy

Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosis

STUDY OF THE EFFECT OF RHYTHMIC AND NON-RHYTHMIC MUSICAL PRIMING ON THE SYNTAX CAPACITY OF PRESBYACOUSTIC OLDER ADULTS

Study and Follow-up of Multiple Endocrine Neoplasia Type 1

Multiple Endocrine Neoplasia

Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

Von Willebrand Diseases

NCT05305794 Phase 3

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

Double Diabetes

Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases

Use of an Infotainment System in MRI in Patients Suffering From Unexpected Anxiety.

Unexpected Anxiety

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

Giant Cell Arteritis (GCA)

Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion

Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study

Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)

Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation

Neuroendocrine Tumors

NCT06588010 Phase 3

Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder

Neurogenic Bladder

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques